ALK immunohistochemistry positive, FISH negative NSCLC is infrequent, but associated with impaired survival following treatment with crizotinib
Titel:
ALK immunohistochemistry positive, FISH negative NSCLC is infrequent, but associated with impaired survival following treatment with crizotinib
Auteur:
Thunnissen, E. Lissenberg-Witte, B.I. van den Heuvel, M.M. Monkhorst, K. Skov, B.G. Sørensen, J.B. Mellemgaard, A. Dingemans, A.M.C. Speel, E.J.M. de Langen, A.J. Hashemi, S.M.S. Bahce, I. van der Drift, M.A. Looijen-Salamon, M.G. Gosney, J. Postmus, P.E. Samii, S.M.S. Duplaquet, F Weynand, B. Durando, X. Penault-Llorca, F. Finn, S. Grady, A.O Oz, B. Akyurek, N. Buettner, R. Wolf, J. Bubendorf, L. Duin, S. Marondel, I. Heukamp, L.C. Timens, W. Schuuring, E.M.D. Pauwels, P. Smit, E.F.